Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature

por Al Sulaiman, Khalid, Alsuwayyid, Faisal, Alrashidi, Abdulrahman, Alhijris, Mohammed, Almutairi, Faisal, Alharthi, Fahad, Abu Esba, Laila Carolina, Aljuhani, Ohoud, Badreldin, Hisham A
Publicado 2022

The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospe...

por Korayem, Ghazwa B., Alshaya, Omar A., Alghamdi, Albandari A., Alanazi, Shahad S., Almutib, Renad T., Alsaileek, Mahdi, Alrashidi, Abdulrahman, Aldosari, Nasser, Bin Sheraim, Nader, Al Yami, Majed S., Almohammed, Omar A.
Publicado 2022

Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study

por Al Sulaiman, Khalid, Badreldin, Hisham A., Korayem, Ghazwa B., Alenazi, Abeer A., Alsuwayyid, Faisal, Alrashidi, Abdulrahman, Alhijris, Mohammed, Almutairi, Faisal, Alharthi, Fahad, Vishwakarma, Ramesh, Al Shaya, Omar, Al Amri, Abdulrahman, Tayyab, Saqiba, Al Bekairy, Abdulkareem M., Aljuhani, Ohoud
Publicado 2022